Product Description
Blood transfusion diagnostics are products used to conduct tests before transfusion of blood and blood products from donor to recipient. These products include instruments such as analyzers and centrifuges, and kits & reagents for various tests such as blood grouping and disease screening for donors as well as patients. Blood screening is a major step in the pre-transfusion process. Various instruments, test kits, and reagents based on molecular and serological techniques are used to detect transfusion transmitted infections (TTIs) along with establishing the compatibility of donor and patient blood group before transfusion.
The Blood Transfusion Diagnostics market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Blood Transfusion Diagnostics market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Blood Transfusion Diagnostics Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Blood Transfusion Diagnostics market are:
BAG Health Care
F. Hoffmann-La Roche
Immucor Inc.
Grifols S.A.
Ortho Clinical Diagnostics
Abbott Diagnostics
DiaSorin
Novartis AG
Bio-rad Laboratories
Quidel Corporation
Becton, Dickinson and Company
Hologic
Proteomes Sciences
Beckman Coulter
Most important types of Blood Transfusion Diagnostics products covered in this report are:
Reagents & Kits
Instruments
Others
Most widely used downstream fields of Blood Transfusion Diagnostics market covered in this report are:
Disease Screening
Molecular Disease Screening
Serological Disease Screening
Blood Screening
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.